Bombay HC Refuses Relief to Udupi Swaad Restaurant for Analogue Paneer, Calls It Poetic Justice

The Bombay High Court delivered a sharp rebuke to a Thane-based restaurant caught serving banned analogue paneer, refusing any interim relief and observing that the establishment must “suffer” just as its unsuspecting customers had. The division bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad labelled the situation “poetic justice” and directed the restaurant to continue bearing the consequences of its licence suspension until the regulator files a formal response.

The ruling underscores the judiciary’s zero-tolerance approach to food adulteration and the deliberate misrepresentation of food products. It also highlights the court’s insistence on transparency in the hospitality industry, particularly when synthetic substitutes are sold under the guise of traditional dairy items.

The FDA Crackdown on Analogue Paneer

The controversy stems from a June 2026 inspection of Udupi Swaad Restaurant in Thane’s Wagle Estate. A laboratory test conducted by the Maharashtra Food and Drug Administration (FDA) found that the paneer served at the eatery was not made from milk but was an “analogue” product—a non-dairy substitute composed of vegetable oils, starches, and chemical additives. The FDA subsequently issued a statewide ban on the manufacture, storage, processing, distribution, and sale of analogue paneer on July 30, 2026, citing serious public health concerns.

On August 11, the FDA suspended the restaurant’s FSSAI licence, prompting the eatery to file a writ petition before the Bombay High Court. The restaurant argued that the regulator had acted without first issuing an improvement notice under Section 32 of the Food Safety and Standards Act, 2006, and that the suspension caused “substantial financial and reputational losses.”

Court’s Sharp Rebuke: “You Are Making People Eat Something Rotten”

During the hearing on August 21, Acting Chief Justice Ghuge expressed visible anger when the restaurant’s counsel sought interim relief. The court questioned whether the establishment had ever informed its customers that the paneer being served was a substitute.

“Have you advertised in your menu card and indicated to customers you are serving them analog paneer? You are making people eat something rotten and you are saying an improvement notice should be given to you?” the Acting Chief Justice observed.

The bench further remarked that customers rely on menu descriptions and ingredient lists when ordering. Serving analogue paneer without disclosure amounts to a deliberate deception that compromises consumer trust and health.

“Why don’t you advertise on your signboard that original food is not available with us? People should know what they are being served,” the court added.

Additional Government Pleader Priyabhushan Kakade, representing the FDA, informed the bench that oil mixed with chemicals is used to produce the duplicate paneer. He emphasised that the product is already banned across Maharashtra for one year.

Poetic Justice: No Interim Relief

The restaurant’s plea for immediate relief was flatly rejected. The court noted that the establishment had continued to serve analogue paneer even after the ban was notified on August 1, with the offending sample having been collected in June.

“Just for little price difference, you do this? But you are still making people eat something by making them believe it is paneer. So now you too suffer for sometime as you made people suffer by eating this. Then you also suffer. No interim relief. If you make people eat this without indicating… You should be penalised,” Acting CJ Ghuge thundered.

He further observed, “You need to suffer first as you have made people suffer by eating this. This is poetic justice.”

The bench directed the FDA to file a detailed reply by September 2 and posted the matter for further hearing on September 7. Until then, the restaurant’s licence suspension remains in force.

Legal Analysis: The Importance of Improvement Notices

One of the central legal arguments advanced by the petitioner was the failure of the FDA to issue an improvement notice under Section 32 of the FSSAI Act before resorting to licence suspension. Under Section 32, a food business operator may be given a notice requiring compliance within a specified period if the regulator reasonably believes that the operator is failing to comply with the Act. The petitioner argued that this procedural safeguard had been ignored.

However, the court was unimpressed with this contention. The bench’s remarks suggest that in cases involving deliberate adulteration or misrepresentation, regulators may bypass the improvement notice route and take direct enforcement action. The severity of the violation—serving a chemically adulterated product without disclosure—justifies immediate suspension.

Legal experts note that this interpretation could have significant implications for the food industry. While the FSSAI Act envisages a graded enforcement mechanism, the Bombay High Court’s stance indicates that courts will not readily second-guess the regulator’s decision to impose an immediate suspension when consumer health is at stake. The ruling also reinforces the principle that procedural defenses cannot shield operators who engage in fraudulent practices.

Implications for the Hospitality Industry

This judgment sends a clear message to restaurants and food businesses across Maharashtra and beyond: transparency is non-negotiable. The use of analogue or substitute products is not illegal per se, provided they are properly labelled and disclosed to consumers. However, passing off a synthetic product as authentic dairy paneer—without any indication on the menu or signboard—constitutes a serious violation of food safety regulations and consumer rights.

The court’s insistence that the restaurant “suffer” first before seeking relief may also deter other establishments from challenging enforcement actions lightly. The denial of interim relief means that the restaurant must endure the financial and reputational damage of a suspended licence for at least several weeks, a consequence that many small businesses may find difficult to withstand.

Moreover, the FDA’s statewide ban on analogue paneer, issued by Food Safety Commissioner Tukaram Mundhe, is part of a broader crackdown on adulterated dairy products. The court’s supportive stance will likely embolden regulators to take swift action against violators without fear of judicial interference at the interim stage.

Conclusion

The Bombay High Court’s decision in Udupi Swaad Restaurant vs Maharashtra FDA is a potent reminder that the judiciary will not tolerate the sale of adulterated or misrepresented food products. By denying relief and invoking the notion of poetic justice, the bench has underscored the need for accountability in the food service industry. As the matter proceeds to the next hearing on September 7, the restaurant’s fate—and the broader legal framework for analogue product regulation—remain under scrutiny.

For legal professionals, this case offers valuable insights into the interplay between procedural safeguards under the FSSAI Act and the inherent power of courts to deny discretionary relief where the underlying conduct is egregious. It also highlights the growing judicial vigilance in matters of public health and consumer protection—a trend likely to continue as food adulteration cases rise across the country.